Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

Clinical trial NCT02617849 · UNKNOWN

Trial details

NCT number: NCT02617849
Sponsor: Wilson Miller
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Melanoma

Start date: 2016-05-19
Primary completion: 2021-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.